new study in collaboration with college mental health leaders Dr. David Walden and Dr. Harry Rockland-Miller. Highlighting findings from 120 U.S. colleges and universities, the study reveals that almost all (91%) college counseling center directors and clinicians have experienced burnout during the 2020 Fall semester due to COVID-19.
Titled
Provider Burnout in Counseling Centers Due to COVID-19: Implications and Recommendations for Improving Work Satisfaction and Overall Well-Being, the study includes the findings from a national survey of U.S. higher education institutions conducted between November 25, 2020 and December 8, 2020. Among the 139 respondents from counseling centers, 79 were directors and 60 were clinicians. The full study offers recommendations from
Coping Through The Holiday Season In South County
There is no doubt that we are
ALL living in trying times as the ongoing COVID-19 pandemic has not let up, just as yet. Even though plans are in the works to inoculate the general public in the coming months, we
STILL have a ways to go. The holiday season is upon us and 2020 is truly making each and every one alter their usual routine in regard to celebrating with family and friends. There is a way to assist those who are experiencing stress during this difficult time.
Berkshire Community College and the Southern Berkshire Rural Health Network have teamed up to a
Combination therapy places no greater burden on early-stage breast cancer patients
Adding an immune checkpoint inhibitor to the standard chemotherapy regimen for patients with early-stage breast cancer places no greater burden on patients ability to perform day-to-day activities than chemotherapy alone, new research by Dana-Farber/Brigham and Women s Cancer Center investigators shows.
The report, coupled with earlier findings that combining checkpoint inhibitors with chemotherapy can increase response rates in patients with early-stage triple-negative breast cancer, offer assurance that the benefits of the combination can be achieved without diminishing patients quality of life, the study authors say.
The study, to be presented at today s virtual session of the San Antonio Breast Cancer Symposium, by Elizabeth Mittendorf, MD, PhD Director of the Breast Immuno-Oncology program at the Dana-Farber/Brigham and Women s Cancer Center, is the first to use patients own feedback to gaug
E-Mail
BOSTON - Adding an immune checkpoint inhibitor to the standard chemotherapy regimen for patients with early-stage breast cancer places no greater burden on patients ability to perform day-to-day activities than chemotherapy alone, new research by Dana-Farber/Brigham and Women s Cancer Center investigators shows.
The report, coupled with earlier findings that combining checkpoint inhibitors with chemotherapy can increase response rates in patients with early-stage triple-negative breast cancer, offer assurance that the benefits of the combination can be achieved without diminishing patients quality of life, the study authors say. The study, to be presented at today s virtual session of the San Antonio Breast Cancer Symposium, by Elizabeth Mittendorf, MD, PhD Director of the Breast Immuno-Oncology program at the Dana-Farber/Brigham and Women s Cancer Center, is the first to use patients own feedback to gauge the impact of the combination therapy on daily functioning for p
Adding checkpoint inhibitor to chemotherapy improves responses without negatively impacting quality of life miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.